DATE4 Aug

NIFTY 24,615 ▼ 0.64%BANK NIFTY 57,907 ▼ 0.58%NIFTY IT 31,454 ▼ 0.82%NIFTY PHARMA 26,598 ▼ 0.24%ATHERENERG 1,450 ▲ 13.96%KEI 5,500 ▲ 9.49%LICI 391 ▼ 8.68%GRAPHITE 710 ▲ 7.92%JAINREC 323 ▼ 7.64%CGPOWER 880 ▲ 6.53%UPL 582 ▼ 6.15%SAREGAMA 543 ▲ 5.51%SAIL 174 ▲ 5.18%MAPMYINDIA 1,140 ▼ 4.71%NIFTY 24,615 ▼ 0.64%BANK NIFTY 57,907 ▼ 0.58%NIFTY IT 31,454 ▼ 0.82%NIFTY PHARMA 26,598 ▼ 0.24%ATHERENERG 1,450 ▲ 13.96%KEI 5,500 ▲ 9.49%LICI 391 ▼ 8.68%GRAPHITE 710 ▲ 7.92%JAINREC 323 ▼ 7.64%CGPOWER 880 ▲ 6.53%UPL 582 ▼ 6.15%SAREGAMA 543 ▲ 5.51%SAIL 174 ▲ 5.18%MAPMYINDIA 1,140 ▼ 4.71%

Morning brief · Wednesday, 5 August 2026

Time Technoplast's ₹10,263 crore question: what's next

Market pulse

A broad based sell off gripped the markets, pulling benchmark indices like the Nifty 50 and Bank Nifty down by over half a percent each. While a handful of stocks like Ather Energy and KEI Industries bucked the trend with strong gains, heavyweights such as LIC and UPL dragged on investor sentiment, closing with significant losses.

From the investor's mind

One post worth your time, explained

@unseenvalue · on X

Sajal Kapoor highlights how many small biotech firms failed to deliver on initial hype, with their market capitalizations rarely doubling from IPO peaks. In contrast, Contract Development and Manufacturing Organizations (CDMOs) in the pharmaceutical sector have quietly achieved substantial growth, compounding 50x, 100x, and even more. Kapoor suggests that "Robotics CDMO" could present a similar opportunity for significant, understated growth in a new sector, drawing a parallel to the sustained success of traditional CDMOs.

Word in the street

What the wider market is buzzing about

Time Technoplast Limited

₹210Past year ▼ 8%M.cap ₹10,263 Cr

Time Technoplast has found itself in the spotlight, and not for the reasons a company might hope. The stock has trailed the broader market, shedding about 8 percent of its value over the last year. This performance has led to a closer examination of the nearly ₹10,263 crore company’s moving parts and its future strategy. Attention has turned toward the company’s capital expenditure and its manufacturing of high-density polyethylene, or HDPE, pipes. The central question being explored is how this specific business line fits within the company’s well-known industrial packaging segment, and what it signals about the path ahead.

Know more about the stock

Yesterday's big moves